September 1, 2018

UC’s unconventional scientist tackles remedy for cystic fibrosis and COPD.

March 21, 2025

MSN highlighted research led by the University of Cincinnati's Jed Hartings detailing how automation and machine learning can aid clinicians treating patients with spreading depolarizations, sometimes referred to as “brain tsunamis.”

March 25, 2025

Local 12 highlighted University of Cincinnati Cancer Center researcher Davendra Sohal and patient Ron Solomon who is enrolled in a pancreatic cancer trial targeting a genetic mutation called KRAS.

March 24, 2025

The University of Cincinnati Cancer Center's Amanda Jackson was featured in a MedPage Today article commenting on new research that found adding metformin as a combination therapy was tied to deep responses and prolonged progression-free survival in some patients with recurrent estrogen receptor-positive endometrial cancer.

March 28, 2025

The Cincinnati Business Courier highlighted a $1.2 million grant received by the University of Cincinnati Cancer Center's Timothy Phoenix and colleagues at Dana-Farber Cancer Institute and the German Cancer Research Center to study pediatric low-grade gliomas.

April 4, 2025

Results from a new Phase 3 trial published in the journal npj Precision Oncology found that an assay that includes an assessment of cancer stem cell sensitivity to chemotherapy can accurately decide more effective treatments and lead to increased outcomes for patients with platinum-resistant ovarian cancer.

April 7, 2025

MSN and MSN UK highlighted results from a new Phase 3 trial published in the journal npj Precision Oncology that found a cancer stem cell test can accurately choose more effective treatments and lead to improved outcomes for patients with platinum-resistant ovarian cancer.

March 20, 2025

OncLive and MedPage Today highlighted research presented by the University of Cincinnati Cancer Center's Thomas Herzog that found a combination therapy of afuresertib and paclitaxel did not lead to better survival outcomes when compared to only treating with paclitaxel in patients with platinum-resistant ovarian cancer.

April 3, 2025

Second-year medical sciences student Jay Patel is pursuing his passions at UC — conducting cancer research, exploring public policy as a Portman Fellow, and leading an international nonprofit foundation.

May 21, 2025

New research led by the University of Cincinnati’s Nalinikanth Kotagiri recently published in the journal Gut Microbes demonstrates how specially engineered bacteria taken orally can operate as a delivery system for vaccines and antiviral therapies.